Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

EQS-Adhoc: BRAIN Biotech AG Appoints Dr. Sven K. Weber as New Chairman of the Executive Board, Effective October 1, 2026Photo, wide shot, wide-angle lens, soft focus,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-d5U47McddROtnUwv1JIaZvc2.png?st=2023-05-04T16%3A11%3A57Z&se=2023-05-04T18%3A11%3A57Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T16%3A04%3A37Z&ske=2023-05-05T16%3A04%3A37Z&sks=b&skv=2021-08-06&sig=KvGLXJQj4L2uYw31IYBsPpHX4telRq/7natMW2uEF58%3D
EQS-Adhoc: BRAIN Biotech AG Appoints Dr. Sven K. Weber as New Chairman of the Executive Board, Effective October 1, 2026
EQS-Adhoc: BRAIN Biotech AG Appoints Dr. Sven K. Weber as New Chairman of the Executive Board, Effective October 1, 2026
Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients: https://g.foolcdn.com/editorial/images/880088/amgen.png
Watch Out, Eli Lilly and Novo Nordisk: Amgen's Monthly Weight Loss Drug Has 6 Phase 3 Trials Running -- and It's Coming for Your Patients

Amgen (NASDAQ: AMGN) is betting that the convenience of its weight loss treatment will make it a winner, and it might be right. Its candidate MariTide is a monthly injection that aims to directly

EQS-News: Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax FundsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-News: Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds
EQS-News: Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds
EQS-Adhoc: Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax FundsPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
EQS-Adhoc: Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds
EQS-Adhoc: Gerresheimer is selling Centor and its global Primary Packaging Plastics business to Apax Funds
Advanced Micro Devices vs. BigBear.ai: Which Technology Stock Is a Better Buy in 2026?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/232304ef0caa6d6d9809b270afde92b613c990f1-1200x800.png?w=800&q=75&fit=max&auto=format
Advanced Micro Devices vs. BigBear.ai: Which Technology Stock Is a Better Buy in 2026?

Are you looking for established chip dominance or a niche software play? Advanced Micro Devices (NASDAQ:AMD) and BigBear.ai (NYSE:BBAI) represent two very different ways to navigate the current

Advanced Micro Devices vs. Arista Networks: Which Tech Stock Is a Better Buy in 2026?: https://cdn.content.foolcdn.com/images/1umn9qeh/production/bf1840c3c19f65b476307d856544619881ecb92d-1200x800.png?w=800&q=75&fit=max&auto=format
Advanced Micro Devices vs. Arista Networks: Which Tech Stock Is a Better Buy in 2026?

The artificial intelligence boom has investors weighing high-growth chips against the infrastructure that connects them. Choosing between Advanced Micro Devices (NASDAQ:AMD) and Arista Networks (NYS

Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case: https://g.foolcdn.com/editorial/images/880074/viking-therapeuticsa-logo.png
Wall Street Says Buy the Dip in Viking Therapeutics. Here's the Bull Case

Shares of Viking Therapeutics (NASDAQ: VKTX), a clinical-stage biotech, have declined by 46% over the past two years. There are several reasons for this. First, longtime shareholders decided to

D-Wave Quantum Just Announced an Expanded Deal. Should You Buy the Stock Now?: https://g.foolcdn.com/editorial/images/880683/d-wave-logo.png
D-Wave Quantum Just Announced an Expanded Deal. Should You Buy the Stock Now?

Shares of D-Wave Quantum (NYSE: QBTS) jumped Monday morning on the announcement that AT&T (NYSE: T) is expanding its use of the company's quantum computing technology across its network operations

3 Dividend Stocks That Are Crushing the Market in 2026: https://g.foolcdn.com/editorial/images/880587/a-person-holding-cash.jpg
3 Dividend Stocks That Are Crushing the Market in 2026

The S&P 500 is up over 8% this year (as of Monday's close), which isn't bad given how hot it's been in recent years. But there is clearly a bit more apprehension in the market these days, with

Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLCPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group PLC
Edison issues report on BB Biotech (BION)Photo, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
Edison issues report on BB Biotech (BION)
Edison issues report on BB Biotech (BION)
Competition Is Growing, but Is Nvidia Really in Trouble? This Numbers Suggests It Isn't: https://g.foolcdn.com/editorial/images/880594/a-person-holding-up-an-artificial-intelligence-chip.jpg
Competition Is Growing, but Is Nvidia Really in Trouble? This Numbers Suggests It Isn't

Tech investors keep seeing and hearing the same headlines about tech companies making their own chips and diversifying away from Nvidia (NASDAQ: NVDA)'s high-priced products. Initially, it's easy to

Why D-Wave Quantum Stock Surged Today: https://g.foolcdn.com/editorial/images/880824/quantum-computing-stocks-gettyimages-2211414345-1901x1002-0cd61c1.jpg
Why D-Wave Quantum Stock Surged Today

Shares of D-Wave Quantum (NASDAQ: QBTS) soared on Monday after the advanced computing pioneer broadened its partnership with AT&T (NYSE: T).

Image source: Getty Images.

Early tests of D-Wave's quan

Should You Buy AbbVie Stock Hand Over Fist Before July 31?: https://g.foolcdn.com/editorial/images/880079/biotech-pharma-researchers-talk-lab-1200x800-5b2df79.jpg
Should You Buy AbbVie Stock Hand Over Fist Before July 31?

Before the market opens on July 31, AbbVie (NYSE: ABBV) will report second-quarter results, hoping to build on the momentum from its Q1 earnings beat. As the key catalyst behind last quarter's

Stock Market Today, July 27: D-Wave Surges on Nasdaq Debut and Expanded AT&T DealPhoto, wide shot, wide-angle lens, soft focus,  Pharmaceutical company, sunset photo at golden hour, photo by Peter Lik: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-TIgKJfhK8q44RPNTTsL9npu7.png?st=2023-05-08T05%3A58%3A04Z&se=2023-05-08T07%3A58%3A04Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-08T02%3A36%3A56Z&ske=2023-05-09T02%3A36%3A56Z&sks=b&skv=2021-08-06&sig=BDDjRcmCPf%2BH//HSxRGZYByMqOKev8lx0/Dhvka/lXk%3D
Stock Market Today, July 27: D-Wave Surges on Nasdaq Debut and Expanded AT&T Deal

D-Wave Quantum (NASDAQ:QBTS), a quantum computing systems and services provider, closed at $19.51, up 20.36%. An expanded agreement with AT&T (NYSE:T) and the stock’s Nasdaq listing debut drove the

AT&T Stock Has Been Quietly Rallying Since the Start of July. After a Strong Q2, Is It Due to Soar Even Higher?: https://g.foolcdn.com/editorial/images/880579/a-person-using-internet-on-their-phone.jpg
AT&T Stock Has Been Quietly Rallying Since the Start of July. After a Strong Q2, Is It Due to Soar Even Higher?

When Space Exploration Technologies Corp (NASDAQ: SPCX), also known as SpaceX, went public last month, telecom stocks went into a bit of a free fall, as there were growing concerns that it would

Why Quantum Computing Stock Just Popped: https://g.foolcdn.com/editorial/images/880718/neon-quantum-computing-sign-floats-in-a-sea-of-qubits.jpg
Why Quantum Computing Stock Just Popped

Quantum Computing (NASDAQ: QUBT) stock gained 5.8% through 12:45 p.m. ET Monday -- and it's got a competitor to thank for it.

This morning, D-Wave Quantum (NYSE: QBTS) announced that AT&T (NYSE: T)

Why Rigetting Computing Stock Just Popped: https://g.foolcdn.com/editorial/images/880713/spherical-quantum-computing-chip.jpg
Why Rigetting Computing Stock Just Popped

Quantum computing stock Rigetti Computing (NASDAQ: RGTI) jumped a lucky 7.7% through 11:50 a.m. ET Monday morning -- and in part, it's got a competitor to thank for it.

This morning, rival quantum

Why Rigetti Computing Stock Just Popped: https://g.foolcdn.com/editorial/images/880713/spherical-quantum-computing-chip.jpg
Why Rigetti Computing Stock Just Popped

Quantum computing stock Rigetti Computing (NASDAQ: RGTI) jumped a lucky 7.7% through 11:50 a.m. ET Monday morning -- and in part, it's got a competitor to thank for it.

This morning, rival quantum

Why IonQ Stock Just Jumped: https://g.foolcdn.com/editorial/images/880696/quantum-particles-traped-in-an-electromagnetic-field-between-two-golden-discs.jpg
Why IonQ Stock Just Jumped

Quantum computing stock IonQ (NYSE: IONQ) jumped 8.4% through 11 a.m. ET Monday morning -- and it's got a competitor to thank for it.

This morning, rival quantum stock D-Wave Quantum (NYSE: QBTS)

VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge  A milestone fully aligned with Valbiotis’ missionPhoto, wide shot, wide-angle lens, soft focus,  Biotech company, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Hiroshi Sugimoto: https://oaidalleapiprodscus.blob.core.windows.net/private/org-IbuNdCATsFaPOITjFOv2kJh3/user-AXaxqjBUW45D8BadJEo9mUpW/img-pKgbwxVSbyTCu0UzPNe8NL8D.png?st=2023-05-04T16%3A02%3A58Z&se=2023-05-04T18%3A02%3A58Z&sp=r&sv=2021-08-06&sr=b&rscd=inline&rsct=image/png&skoid=6aaadede-4fb3-4698-a8f6-684d7786b067&sktid=a48cca56-e6da-484e-a814-9c849652bcb3&skt=2023-05-04T12%3A13%3A51Z&ske=2023-05-05T12%3A13%3A51Z&sks=b&skv=2021-08-06&sig=%2BhYssNp3W0HiZMxCV64XVELyP8stYUjFhgUVfPrTLyg%3D
VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge A milestone fully aligned with Valbiotis’ mission
VALBIOTIS SA: Cardiovascular Prevention Act: A response to a major public health challenge A milestone fully aligned with Valbiotis’ mission
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plcPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc
AT&T Beat on Earnings, Announced a $10 Billion Buyback, and Still Trades at 8 Times Earnings With a 4.6% Yield.: https://g.foolcdn.com/editorial/images/880628/large-office-building-with-_att-logo-on-front_att.jpg
AT&T Beat on Earnings, Announced a $10 Billion Buyback, and Still Trades at 8 Times Earnings With a 4.6% Yield.

The market has spent years treating AT&T (NYSE: T) as a bond that happens to trade on an exchange. Slow growth, a big dividend, and not much to think about in between.

The company's second-quarter

3 Absurdly Cheap Dividend Stocks to Buy Before August: https://g.foolcdn.com/editorial/images/880080/getty-dividend-income-1200x800-5b2df79.jpg
3 Absurdly Cheap Dividend Stocks to Buy Before August

When it comes to high-yield dividend stocks, it's not a matter of quantity, but of quality. There are numerous stocks with forward dividend yields of 5% or higher, but many of them are firmly in the

Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?: https://g.foolcdn.com/editorial/images/874969/getty-thinking-wondering-striped-shirt-deciding.jpg
Better Dividend King to Buy Right Now: AbbVie or Johnson & Johnson?

Dividend Kings are companies that have increased their dividends for 50 or more years in a row. If you're thinking of investing in one, you might be considering AbbVie (NYSE: ABBV) or Johnson &amp